Inhibikase Therapeutics, Inc.
IKT
Revenue
0.00
0.000.00%
6 Months ChangeAssets
94.28M
▼-4.32M▼-4.38%
3 Months ChangeLiabilities
8.55M
▲4.82M▲129.02%
3 Months ChangeFree Cash Flow
-4.12M
▼-249.91k▼-6.46%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-22
Form 8-K
ID: 0001193125-24-240603
2024-10-10
Form 8-K
ID: 0001193125-24-236039
2024-10-09
Form 8-K
ID: 0001193125-24-234814
2024-08-14
Form 10-Q
ID: 0000950170-24-097022
2024-08-06
Form 8-K
ID: 0001193125-24-194177
2024-06-10
Form 8-K
ID: 0001193125-24-158318
2024-05-20
Form 8-K
ID: 0001193125-24-142317
2024-05-15
Form 10-Q
ID: 0000950170-24-060579
2024-04-30
Form 8-K
ID: 0001193125-24-123758
2024-04-19
Form 8-K
ID: 0001193125-24-101292